(Q33728732)

28 July 2017

1 reference

title

Painful diabetic neuropathy. (English)

1 reference

28 July 2017

Benbow SJ

1

1 reference

PubMed ID

10477207

28 July 2017

Cossins L

series ordinal

2

1 reference

PubMed ID

10477207

28 July 2017

MacFarlane IA

series ordinal

3

1 reference

28 July 2017

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

16

1 reference

28 July 2017

8

1 reference

28 July 2017

632-644

1 reference

Diabetic peripheral neuropathy and quality of life.

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The natural history of acute painful neuropathy in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Chronic and remitting painful diabetic polyneuropathy. Correlations with clinical features and subsequent changes in neurophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The Prevalence of Diabetic Distal Sensory Neuropathy in an English Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The symptom patterns of treated diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The natural history of painful diabetic neuropathy--a 4-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Pathophysiology and treatment of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Pain in peripheral neuropathy related to rate and kind of fiber degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Pain due to peripheral nerve damage: an hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Development of ongoing activity, mechanosensitivity, and adrenaline sensitivity in severed peripheral nerve axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Ephaptic transmission in chronically damaged peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Coupling between unmyelinated peripheral nerve fibers does not involve sympathetic efferent fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Effect of hyperglycemia on pain threshold in alloxan-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Does acute hyperglycaemia influence heat pain thresholds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Causes of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Neurogenic pain syndromes and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Intravenous regional sympathetic block with guanethidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Regional intravenous guanethidine vs. Stellate ganglion block in reflex sympathetic dystrophies: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Plasma norepinephrine in sensory diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Pain mechanisms: a new theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The gate-control theory of pain. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

A comparison of four tests for assessing the pain sensitivity of different subjects and test areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The McGill Pain Questionnaire: Major properties and scoring methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Spinal and Trigeminal Mechanisms of Nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Depression masquerading as diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Peripheral Diabetic Neuropathy Treated With Amitriptyline and Fluphenazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Gabapentin: a new agent for the management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Analgesic responses to i.v. lignocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Capsaicin: actions on nociceptive C-fibres and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Capsaicin and sensory neurones — a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Specificity spillover at the hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Treatment of painful diabetic neuropathy with capsaicin 0.075%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The effectiveness of topically applied capsaicin. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Topical Capsaicin in Painful Diabetic Neuropathy: Effect on Sensory Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Spinal cord stimulation for chronic pain in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Spinal cord stimulation and pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Application of OpSite film: a new and effective treatment of painful diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Aldose reductase inhibitors: the end of an era or the need for different trial designs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Transdermal clonidine versus placebo in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Lack of effect of clonidine and pentoxifylline in short-term therapy of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Baclofen as an analgesic in chronic peripheral nerve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

The influence of pyridoxine in diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Cyclandelate in diabetic neuropathy. A double-blind, placebo-controlled, randomized, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Octreotide, a long-acting somatostatin analogue, in diabetic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Smoking habits and painful diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Absence of evidence is not evidence of absence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Properties of afferent nerve impulses originating from a neuroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00028.X

Elevated glycosylated hemoglobin in diabetic neuropathy

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1007/BF02629257

Identifiers

DOI

10.1046/J.1464-5491.1999.00028.X

1 reference

28 July 2017

1 reference

PubMed ID

10477207